Global Auto-Retractable Safety Syringe Market Research Report 2023-Competitive Analysis, Status and Outlook by Type, Downstream Industry, and Geography, Forecast to 2029

Global Auto-Retractable Safety Syringe Market Research Report 2023-Competitive Analysis, Status and Outlook by Type, Downstream Industry, and Geography, Forecast to 2029

Auto-retarctable Safety Syringe is a kind of syringe which has a safety mechanism built into the syringe. The needle on auto-retarctable safety syringe can be detachable or permanently attached. On some models, a sheath is placed over the needle or the needle retracts into the barrel following injection to protect healthcare workers and others from accidental needlestick injuries.

Market Overview:

The latest research study on the global Auto-Retractable Safety Syringe market finds that the global Auto-Retractable Safety Syringe market reached a value of USD 926.31 million in 2022. It’s expected that the market will achieve USD 2358.27 million by 2028, exhibiting a CAGR of 16.85% during the forecast period.

Influence of COVID-19 Outbreak on Auto-Retarctable Safety Syringe Industry Development

The Occupational Safety and Health Administration of the United States and the World Health Organization recommend the use of retractable needles as a way to reduce the spread of blood-borne diseases. In order to reduce cross infection, Auto-Retarctable Safety Syringe has become a popular way. At present, there are already some vaccine products using Auto-Retarctable Safety Syringe. covid-19 has promoted the Auto-Retarctable Safety Syringe market to a certain extent.

In order to curb the COVID-19 epidemic, most countries have introduced many policies, including border blockade and social distancing. The epidemic prevention and control measures will affect the flow of people and activities, and in turn affect logistics, making the production of manufacturing, especially labor-intensive industries, affected by the supply of raw materials and labor shortages.

For the Auto-Retarctable Safety Syringe industry, the blockade policy will affect the supply of raw materials and export trade of products. The social distancing policy may have a great impact on the production of products, especially for some small factories, they will spend more money to maintain production during the epidemic, and factories may face the risk of closure in some areas. With the gradual control of the epidemic, some factories began to resume operation. However, while operating production, enterprises need to protect the life and health of employees, such as purchasing masks, disinfectants and other epidemic prevention materials, disinfecting the working environment before and after the production, and testing the body temperature of employees every day to ensure the health of employees. These measures will increase the production cost of enterprises and affect the development of enterprises.

However, in the long run, the COVID-19 epidemic will cause more production plants to start using more automated production lines, so as to avoid the impact of the pandemic on the industry. In addition, the application of Internet of Things technology may also bring more opportunities for industry participants.

Auto-Retarctable Safety Syringe Drivers

Medical supplies are widely used for the geriatric population as it assists the healthcare professionals to administer medication/ hormone/ nutrition and others. For instance, cancer is a major cause of morbidity and mortality in aging population that later primarily attributable to various chronic complications. The number of aging people with cancer is increasing due to increased lifespan and the increased prevalence of cancer in the geriatric population worldwide. The elderly population is defined as a group of people aged 65 and over. Population aging is poised to become one of the most significant social transformations of the twenty-first century. According to the report of the United Nations, in 2017, there were approximately 962 million people aged 60 or over across the globe, that consists of 13% of the global population. The population aged 60 or above is growing at a rate of about 3 percent per year. Across the globe, the number of persons aged 80 or above is projected to triple by 2050. The approximate population is around 137 million in 2017, which will reach up to 425 million in 2050. The value is expected to increase to 909 million in 2100, around seven times its value in 2017. The elderly people are more likely to have cancer than younger people, and the effect of the disease on quality of life is particularly deep in this population. With an increase in the number of geriatric population, the prevalence of chronic diseases has increased. Auto-retartable safety syringe is used to treat cancer, diabetes, tuberculosis, polygenic diseases and other diseases because of their time-saving and safety advantages. In the forecast period, the demand for Auto-Retarctable Safety Syringe is expected to increase with the growth of the elderly population.

Region Overview:

From 2023-2028, North America is estimated to witness robust growth prospects.

Company Overview:

BD is one of the major players operating in the Auto-Retractable Safety Syringe market, holding a share of 36.03% in 2021.

Becton, Dickinson and Company is a global medical technology company engaged principally in the development, manufacture, and sale of medical devices, instrument systems, and reagents used by healthcare institutions, life science researchers, clinical laboratories, the pharmaceutical industry, and the general public.

Retractable Technologies, Inc. has been the pioneer in providing the highest quality and most user-friendly safety devices on the market. RTI is dedicated to addressing healthcare safety issues and protecting clinicians from needlestick injuries by designing unrivaled products that significantly reduce exposure to contaminated sharps.

Segmentation Overview:

Among different product types, 3 ml segment is anticipated to contribute the largest market share in 2028.

Application Overview:

By application, the Subcutaneous (Sub-Q) segment occupied the biggest share from 2018 to 2022.

Key Companies in the global Auto-Retractable Safety Syringe market covered in Chapter 3:

C-Major Medical
Gerresheimer AG
DMC Medical
BD
Mediprim GmbH
Retrago
Duopross Meditech Corporation
Retractable Technologies, Inc.
Haiou Medical

In Chapter 4 and Chapter 14.2, on the basis of types, the Auto-Retractable Safety Syringe market from 2018 to 2029 is primarily split into:
0.5 ml
1 ml
3 ml
5 ml
Others

In Chapter 5 and Chapter 14.3, on the basis of Downstream Industry, the Auto-Retractable Safety Syringe market from 2018 to 2029 covers:

Intravenous (IV)
Intramuscular (IM)
Subcutaneous (Sub-Q)

Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2018-2029) of the following regions are covered in Chapter 8 to Chapter 14:

North America (United States, Canada)
Europe (Germany, UK, France, Italy, Spain, Russia, Netherlands, Turkey, Switzerland, Sweden)
Asia Pacific (China, Japan, South Korea, Australia, India, Indonesia, Philippines, Malaysia)
Latin America (Brazil, Mexico, Argentina)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa)